Cited by 310Alzheimer's disease research and treatmentsFatty Acid Research and HealthDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study

Open access

Snowden, Stuart G., Ebshiana, Amera A., Hye, Abdul, An, Yang, Pletnikova, Olga, O’Brien, Richard, Troncoso, John, Legido-Quigley, Cristina, Thambisetty, Madhav·2017·PLOS Medicine

DOI 10.1371/journal.pmed.1002266PMC PMC5360226

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The metabolic basis of Alzheimer disease (AD) pathology and expression of AD symptoms is poorly understood. Omega-3 and -6 fatty acids have previously been linked to both protective and pathogenic effects in AD. However, to date little is known about how the abundance of these species is affected by differing levels of disease pathology in the brain. METHODS AND FINDINGS: We performed metabolic profiling on brain tissue samples from 43 individuals ranging in age from 57 to 95 y old who were stratified into three groups: AD (N = 14), controls (N = 14) and "asymptomatic Alzheimer's disease" (ASYMAD), i.e., individuals with significant AD neuropathology at death but without evidence for cognitive impairment during life (N = 15) from the autopsy sample of the Baltimore Longitudinal Study of Aging (BLSA). We measured 4,897 metabolite features in regions both vulnerable in the middle frontal and inferior temporal gyri (MFG and ITG) and resistant (cerebellum) to classical AD pathology. The levels of six unsaturated fatty acids (UFAs) in whole brain were compared in controls versus AD, and the differences were as follows: linoleic acid (p = 8.8 x 10-8, FC = 0.52, q = 1.03 x 10-6), linolenic acid (p = 2.5 x 10-4, FC = 0.84, q = 4.03 x 10-4), docosahexaenoic acid (p = 1.7 x 10-7, FC = 1.45, q = 1.24 x 10-6), eicosapentaenoic acid (p = 4.4 x 10-4, FC = 0.16, q = 6.48 x 10-4), oleic acid (p = 3.3 x 10-7, FC = 0.34, q = 1.46 x 10-6), and arachidonic acid (p = 2.98 x 10-5, FC = 0.75, q = 7.95 x 10-5). These fatty acids were strongly associated with AD when comparing the groups in the MFG and ITG, respectively: linoleic acid (p < 0.0001, p = 0.0006), linolenic acid (p < 0.0001, p = 0.002), docosahexaenoic acid (p < 0.0001, p = 0.0024), eicosapentaenoic acid (p = 0.0002, p = 0.0008), oleic acid (p < 0.0001, p = 0.0003), and arachidonic acid (p = 0.0001, p = 0.001). Significant associations were also observed between the abundance of these UFAs with neuritic plaque and neurofibrillary tangle burden as well as domain-specific cognitive performance assessed during life. Based on the regional pattern of differences in brain tissue levels of these metabolites, we propose that alterations in UFA metabolism represent both global metabolic perturbations in AD as well as those related to specific features of AD pathology. Within the middle frontal gyrus, decrements in linoleic acid, linolenic acid, and arachidonic acid (control>ASYMAD>AD) and increases in docosahexanoic acid (AD>ASYMAD>control) may represent regionally specific threshold levels of these metabolites beyond which the accumulation of AD pathology triggers the expression of clinical symptoms. The main limitation of this study is the relatively small sample size. There are few cohorts with extensive longitudinal cognitive assessments during life and detailed neuropathological assessments at death, such as the BLSA. CONCLUSIONS: The findings of this study suggest that unsaturated fatty acid metabolism is significantly dysregulated in the brains of patients with varying degrees of Alzheimer pathology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1002266

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Fig 1 Boxplots showing the effect of disease status on the abundance of six UFAs in the CB, ITG, and MFG. Dysregulation of six UFAs shown by boxplots of three disease statuses separated by brain region A) arachidonic acid (AA), B) oleic acid (OLA), C) eicosapentaenoic acid (EPA), D) linolenic acid (LNA), E) linoleic acid (LA), F) docosahexaenoic acid (DHA). AS, asymptomatic Alzheimer; CN, control; DM, Dementia/Alzheimer.CC0 · PubMed Central

Fig 2 Forest plot showing the relationship of the abundance of six UFAs in the MFG and five measures of cognitive performance. A) Association between UFA levels and longitudinal cognitive performance. B) Association between UFA levels and cognitive performance at the last visit prior to death. AA, arachidonic acid; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; LA, linoleic acid; LNA, linolenic acid; OLA, oleic acid; STD, Standard.CC0 · PubMed Central

Fig 3 Overview of omega-3 and omega-6 UFA metabolism showing the potential association between the measured UFAs. Metabolites highlighted in red have been associated with increased risk of disease pathology, with metabolites highlighted in green have been associated with decreased risk of disease pathology. COX, cyclooxygenase; CYP450, cytochrome P450; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; LCD, lineoyl-CoA desaturase; LOX, lipoxygenase; PLA2, phospholipase A2.CC0 · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Metabolomics — the link between genotypes and phenotypes
Fiehn, O. (2002) · Springer eBooks · doi:10.1007/978-94-010-0448-0_11 · Cited by 3,168
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Resolvins
Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., & Moussignac, R.-L. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020760 · Cited by 1,650
Omega-3 fatty acids EPA and DHA: Health benefits throughout life
Swanson, D., Block, R., & Mousa, S. A. (2012) · Advances in Nutrition · doi:10.3945/an.111.000893 · Cited by 1,575
Metabolomics--the link between genotypes and phenotypes.
Fiehn, O. (2002) · PubMed · Cited by 1,517

Show all 68 references

Sorted by citations

Partial least squares-discriminant analysis (PLS-DA) for classification of high-dimensional (HD) data: a review of contemporary practice strategies and knowledge gaps
Lee, L. C., Liong, C.-Y., & Jemain, A. A. (2018) · The Analyst · doi:10.1039/c8an00599k · Cited by 823
Lipids and Alzheimer’s Disease
Kao, Y.-C., Ho, P.-C., Tu, Y.-K., Jou, I.-M., & Tsai, K.-J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041505 · Cited by 485
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study
Varma, V. R., Oommen, A. M., Varma, S., Casanova, R., An, Y., Andrews, R. M., O’Brien, R., Pletniková, O., Troncoso, J. C., Toledo, J. B., et al. (2018) · PLoS Medicine · doi:10.1371/journal.pmed.1002482 · Cited by 469
Self-citation
Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise
Yin, F. (2023) · The FEBS Journal · doi:10.1111/febs.16344 · Cited by 441
Guide to Metabolomics Analysis: A Bioinformatics Workflow
Chen, Y., Li, E., & Xu, L. (2022) · Metabolites · doi:10.3390/metabo12040357 · Cited by 391
Involvement of Lipids in Alzheimer’s Disease Pathology and Potential Therapies
Chew, H., Solomon, V. A., & Fonteh, A. N. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00598 · Cited by 353
Relationships of Dietary Patterns, Foods, and Micro- and Macronutrients with Alzheimer’s Disease and Late-Life Cognitive Disorders: A Systematic Review
Solfrizzi, V., Custodero, C., Lozupone, M., Imbimbo, B. P., Valiani, V., Agosti, P., Schilardi, A., D’Introno, A., Montagna, M. L., Calvani, M., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170248 · Cited by 358
The biological pathways of Alzheimer disease: a review
Calabrò, M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2020) · AIMS neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 287
Application of Metabolomics in Alzheimer’s Disease
Wilkins, J. M., & Trushina, E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2017.00719 · Cited by 268
Cognitive impact of COVID-19: looking beyond the short term
Miners, J. S., Kehoe, P. G., & Love, S. (2020) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00744-w · Cited by 261
The Potential Role of Gut Microbiota in Alzheimer’s Disease: From Diagnosis to Treatment
Varesi, A., Pierella, E., Romeo, M., Piccini, G. B., Alfano, C., Bjørklund, G., Oppong, A., Ricevuti, G., Esposito, C., Chirumbolo, S., et al. (2022) · Nutrients · doi:10.3390/nu14030668 · Cited by 225
Gas chromatography-mass spectrometry-based analytical strategies for fatty acid analysis in biological samples
Chiu, H.-H., & Kuo, C. (2019) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2019.10.003 · Cited by 242
Metabolomics: small molecules that matter more
Muthubharathi, B. C., Gowripriya, T., & Balamurugan, K. (2021) · Molecular Omics · doi:10.1039/d0mo00176g · Cited by 226
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
Pan, L., Han, P., Ma, S., Peng, R., Wang, C., Kong, W., Cong, L., Fu, J., Zhang, Z., Yu, H., et al. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.10.007 · Cited by 204
Brain docosahexaenoic acid uptake and metabolism
Lacombe, R. J. S., Chouinard‐Watkins, R., & Bazinet, R. P. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.12.004 · Cited by 225
Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders
Salvadores, N., Sanhueza, M., Manque, P., & Court, F. A. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00451 · Cited by 182
Integrative metabolomics‐genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease
Horgusluoglu, E., Neff, R., Song, W., Wang, M., Wang, Q., Arnold, M., Krumsiek, J., Galindo‐Prieto, B., Ming, C., Nho, K., et al. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12468 · Cited by 175
Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer’s Disease
Sun, Y., Ma, C., Sun, H. J., Wang, H., Wei, P., Zhou, Z., Wang, H., Pi, C., Shi, Y., & He, X. (2020) · Journal of Diabetes Research · doi:10.1155/2020/4981814 · Cited by 181
Fatty acid metabolism in the progression and resolution of CNS disorders
Bogie, J. F. J., Haidar, M., Kooij, G., & Hendriks, J. J. A. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.01.004 · Cited by 167
Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study
Mahajan, U. V., Varma, V., Griswold, M., Blackshear, C., An, Y., Oommen, A., Varma, S., Troncoso, J., Pletnikova, O., O'Brien, R., et al. (2020) · PLoS Medicine · doi:10.1371/journal.pmed.1003012 · Cited by 144
Self-citation
Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases
Morris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 155
Almond, hazelnut and walnut, three nuts for neuroprotection in Alzheimer’s disease: A neuropharmacological review of their bioactive constituents
Gorji, N., Moeini, R., & Memariani, Z. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.12.003 · Cited by 154
Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis
Huo, Z., Yu, L., Yang, J., Zhu, Y., Bennett, D. A., & Zhao, J. (2019) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2019.10.014 · Cited by 147
Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence
Hampel, H. J., Nisticò, R., Seyfried, N. T., Levey, A. I., Modeste, E. S., Lemercier, P., Baldacci, F., Toschi, N., Garaci, F., Perry, G. L., et al. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101346 · Cited by 147
Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer’s disease
Whiley, L., Chappell, K. E., D’Hondt, E., Lewis, M. R., Jiménez, B., Snowden, S. G., Soininen, H. S., Kłoszewska, I., Mecocci, P., Tsolaki, M., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00741-z · Cited by 126
Self-citation
Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects
Tong, B., Ba, Y., Li, Z., Yang, C., Su, K., Qi, H., Zhang, D., Liu, X., Wu, Y., Chen, Y., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106505 · Cited by 117
Microbiome-metabolome signatures in mice genetically prone to develop dementia, fed a normal or fatty diet
Sanguinetti, E., Collado, M. C., Marrachelli, V. G., Monleón, D., Selma‐Royo, M., Pardo-Tendero, M., Burchielli, S., & Iozzo, P. (2018) · Scientific Reports · doi:10.1038/s41598-018-23261-1 · Cited by 117
The Diverse Roles of microRNAs at the Host–Virus Interface
Bernier, A., & Sagan, S. M. (2018) · Viruses · doi:10.3390/v10080440 · Cited by 109
Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain
Tu, J., Yin, Y., Xu, M., Wang, R., & Zhu, Z. (2017) · Metabolomics · doi:10.1007/s11306-017-1304-x · Cited by 107
Lipids as biomarkers of brain disorders
Hussain, G., Anwar, H., Rasul, A., Imran, A., Qasim, M., Zafar, S., Imran, M., Kamran, S., Aziz, N., Razzaq, A., et al. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1529653 · Cited by 105
A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion
Flury, A. G., Aljayousi, L., Park, H.-J., Khakpour, M., Mechler, J., Aziz, S., McGrath, J. D., Deme, P., Sandberg, C., Ibáñez, F. G., et al. (2024) · Neuron · doi:10.1016/j.neuron.2024.11.018 · Cited by 102
Multiomics technologies: role in disease biomarker discoveries and therapeutics
Dar, M. A., Arafah, A. M., Bhat, K. A., Khan, A., Khan, M. S., Ali, A., Ahmad, S. M., Rashid, S. M., & Rehman, M. U. (2022) · Briefings in Functional Genomics · doi:10.1093/bfgp/elac017 · Cited by 102
Extensive accumulation of misfolded protein aggregates during natural aging and senescence
Cuanalo-Contreras, K., Schulz, J., Mukherjee, A., Park, K.-W., Armijo, E., & Soto, C. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1090109 · Cited by 92
A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
Shi, L., Baird, A. L., Westwood, S., Hye, A., Dobson, R., Thambisetty, M., & Lovestone, S. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170531 · Cited by 92
Self-citation
Neurotransmitter Imbalance in the Brain and Alzheimer’s Disease Pathology
Snowden, S. G., Ebshiana, A. A., Hye, A., Pletniková, O., O’Brien, R., An, Y., Troncoso, J. C., Legido‐Quigley, C., & Thambisetty, M. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190577 · Cited by 89
Self-citation
The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases
Rozpędek-Kamińska, W., Siwecka, N., Wawrzynkiewicz, A., Wojtczak, R., Pytel, D., Diehl, J. A., & Majsterek, I. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062108 · Cited by 84
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort
Kim, M. G., Snowden, S. G., Suvitaival, T., Ali, A., Merkler, D. J., Ahmad, T., Westwood, S., Baird, A. L., Proitsi, P., Nevado‐Holgado, A. J., et al. (2019) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2019.03.004 · Cited by 88
Self-citation
Huanglian Jiedu decoction remodels the periphery microenvironment to inhibit Alzheimer’s disease progression based on the “brain-gut” axis through multiple integrated omics
Gu, X., Zhou, J., Zhou, Y., Wang, H., Si, N., Ren, W., Zhao, W., Fan, X., Gao, W., Wei, X., et al. (2021) · Alzheimer's Research & Therapy · doi:10.1186/s13195-021-00779-7 · Cited by 81
Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer’s Disease
Huan, T., Tran, T., Zheng, J., Sapkota, S., MacDonald, S. W. S., Camicioli, R. M., Dixon, R. A., & Li, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180711 · Cited by 81
Alteration of Metabolic Profile and Potential Biomarkers in the Plasma of Alzheimer’s Disease
Shao, Y., Ouyang, Y., Li, T., Liu, X., Xu, X., Li, S., Xu, G., & Le, W. (2020) · Aging and Disease · doi:10.14336/ad.2020.0217 · Cited by 79
Mediterranean and MIND Diets Containing Olive Biophenols Reduces the Prevalence of Alzheimer’s Disease
Omar, S. H. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112797 · Cited by 82
Sexual differences in mitochondrial and related proteins in rat cerebral microvessels: A proteomic approach
Čikić, S., Chandra, P. K., Harman, J. C., Rutkai, I., Katakam, P. V. G., Guidry, J. J., Gidday, J. M., & Busija, D. W. (2020) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x20915127 · Cited by 74
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Lista, S., González‐Domínguez, R., López‐Ortiz, S., González‐Domínguez, Á., Menéndez, H., Martín-Hernández, J., Lucía, A., Emanuele, E., Centonze, D., Imbimbo, B. P., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101987 · Cited by 76
Lipids in Pathophysiology and Development of the Membrane Lipid Therapy: New Bioactive Lipids
Torres, M., Parets, S., Fernández-Díaz, J., Beteta-Göbel, R., Rodríguez-Lorca, R., Román, R., Lladó, V., Rosselló, C. A., Fernández‐García, P., & Escribá, P. V. (2021) · Membranes · doi:10.3390/membranes11120919 · Cited by 80
Biological sex and DNA repair deficiency drive Alzheimer’s disease via systemic metabolic remodeling and brain mitochondrial dysfunction
Demarest, T. G., Varma, V. R., Estrada, D. J., Babbar, M., Basu, S., Mahajan, U. V., Moaddel, R., Croteau, D. L., Thambisetty, M., Mattson, M. P., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02152-8 · Cited by 74
Self-citation
Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
Zhang, X., Liu, W., Zan, J., Wu, C., & Tan, W. (2020) · Scientific Reports · doi:10.1038/s41598-020-71510-z · Cited by 69
Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?
Chiurchiù, V., Tiberi, M., Matteocci, A., Fazio, F., Siffeti, H., Saracini, S., Mercuri, N. B., & Sancesario, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116235 · Cited by 73
The Role of Lipids, Lipid Metabolism and Ectopic Lipid Accumulation in Axon Growth, Regeneration and Repair after CNS Injury and Disease
Roy, D., & Tedeschi, A. (2021) · Cells · doi:10.3390/cells10051078 · Cited by 70
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Luo, Y., Yang, L.-L., & Yao, X. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00720-0 · Cited by 75
Oligomeric amyloid-beta induces MAPK-mediated activation of brain cytosolic and calcium-independent phospholipase A2 in a spatial-specific manner
Palavicini, J. P., Wang, C., Chen, L., HoSang, K. M., Wang, J., Tomiyama, T., Mori, H., & Han, X. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0460-6 · Cited by 62
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease
Cao, Y., Zhao, L.-W., Chen, Z.-X., & Li, S.-H. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1430465 · Cited by 65
Blood fatty acids in Alzheimer’s disease and mild cognitive impairment: A meta-analysis and systematic review
Hosseini, M., Poljak, A., Braidy, N., Crawford, J. D., & Sachdev, P. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101043 · Cited by 65
Innate sensing of mechanical properties of brain tissue by microglia
Ayata, P., & Schaefer, A. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.01.003 · Cited by 57
Inflammation, Lipid (Per)oxidation, and Redox Regulation
Dias, I. H. K., Milic, I., Heiß, C., Ademowo, O. S., Polidori, M. C., Devitt, A., & Griffiths, H. R. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8022 · Cited by 57
Free Fatty Acids Signature in Human Intestinal Disorders: Significant Association between Butyric Acid and Celiac Disease
Baldi, S., Menicatti, M., Nannini, G., Niccolai, E., Russo, E., Ricci, F., Pallecchi, M., Romano, F., Pedone, M., Poli, G., et al. (2021) · Nutrients · doi:10.3390/nu13030742 · Cited by 62
Phenylalanine Metabolism Is Dysregulated in Human Hippocampus with Alzheimer’s Disease Related Pathological Changes
Liu, P., Yang, Q., Yu, N., Cao, Y., Wang, X., Wang, Z., Qiu, W.-Y., & Ma, C. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210461 · Cited by 59
Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging
Cleland, N. R. W., Al‐Juboori, S. I., Dobrinskikh, E., & Bruce, K. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02305-w · Cited by 62
Hippocampal Mossy Fibers Synapses in CA3 Pyramidal Cells Are Altered at an Early Stage in a Mouse Model of Alzheimer's Disease
Viana da Silva, S., Zhang, P., Haberl, M. G., Labrousse, V., Grosjean, N., Blanchet, C., Frick, A., & Mulle, C. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.2868-18.2019 · Cited by 58
Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group
Jia, T., Chu, C., Liu, Y., van Dongen, J., Papastergios, E., Armstrong, N. J., Bastin, M. E., Carrillo‐Roa, T., den Braber, A., Harris, M. A., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0605-z · Cited by 60
Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease
Caria, A. C. I., Nonaka, C. K. V., Cavalcante, B. R. R., Sousa, R. A. L. D., Aras, R., & Souza, B. S. D. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144977 · Cited by 57
Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function
Liu, Y., Gu, X., Li, Y., Wang, F., Vyas, C. M., Peng, C., Dong, D., Li, Y., Zhang, Y., Zhang, Y., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03891-5 · Cited by 55
Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation
Moutinho, M., Codocedo, J. F., Puntambekar, S. S., & Landreth, G. E. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021807 · Cited by 57
Omics-based biomarkers discovery for Alzheimer's disease
Aerqin, Q., Wang, Z.-T., Wu, K., He, X., Dong, Q., & Yu, J. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04614-6 · Cited by 56
Lipid metabolism in microglia: Emerging mechanisms and therapeutic opportunities for neurodegenerative diseases (Review)
Sun, Y., Wei, K., Liao, X., Wang, J., Gao, L., & Pang, B. (2025) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2025.5580 · Cited by 63
Interactions of polyunsaturated fatty acids with amyloid peptides Aβ40 and Aβ42
Shatshat, A. E., Pham, A. T., & Rao, P. P. N. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.12.027 · Cited by 53
High‐fat diet protects the blood–brain barrier in an Alzheimer's disease mouse model
Goldman, S. E., Goez, D., Last, D., Naor, S., Zaltsman, S. L., Sharvit‐Ginon, I., Atrakchi, D., Shemesh, C., Twitto‐Greenberg, R., Tsach, S., et al. (2018) · Aging Cell · doi:10.1111/acel.12818 · Cited by 52
Cannabinoidomics – An analytical approach to understand the effect of medical Cannabis treatment on the endocannabinoid metabolome
Berman, P., Sulimani, L., Gelfand, A., Amsalem, K., Lewitus, G. M., & Meiri, D. (2020) · Talanta · doi:10.1016/j.talanta.2020.121336 · Cited by 48
Functional consequences of brain exposure to saturated fatty acids: From energy metabolism and insulin resistance to neuronal damage
Sánchez‐Alegría, K., & Arias, C. (2022) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.386 · Cited by 48
Relationship between Wine Consumption, Diet and Microbiome Modulation in Alzheimer’s Disease
Moreno-Arribas, M. V., Bartolomé, B., Peñalvo, J. L., Pérez‐Matute, P., & Motilva, M. (2020) · Nutrients · doi:10.3390/nu12103082 · Cited by 50
Metabolic Profiling of Neocortical Tissue Discriminates Alzheimer’s Disease from Mild Cognitive Impairment, High Pathology Controls, and Normal Controls
Jasbi, P., Shi, X., Chu, P. S., Elliott, N. M., Hudson, H., Jones, D. C., Serrano, G. E., Chow, B., Beach, T. G., Liu, L., et al. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.1c00290 · Cited by 46
Blood‐based bioenergetic profiling reveals differences in mitochondrial function associated with cognitive performance and Alzheimer's disease
Mahapatra, G., Gao, Z., Bateman, J. R., Lockhart, S. N., Bergstrom, J., DeWitt, A. R., Piloso, J. E., Kramer, P. A., Gonzalez-Armenta, J. L., Amick, K. A., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12731 · Cited by 47
Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer’s Disease
Cerasuolo, M., Di Meo, I., Auriemma, M. C., Paolisso, G., Papa, M., & Rizzo, M. R. (2024) · Biomolecules · doi:10.3390/biom14111362 · Cited by 47
Non-Alcoholic Fatty Liver Disease, and the Underlying Altered Fatty Acid Metabolism, Reveals Brain Hypoperfusion and Contributes to the Cognitive Decline in APP/PS1 Mice
Pinçon, A., de Montgolfier, O., Akkoyunlu, N., Daneault, C., Pouliot, P., Villeneuve, L. R., Lesage, F., Levy, B. I., Thorin‐Trescases, N., Thorin, É., et al. (2019) · Metabolites · doi:10.3390/metabo9050104 · Cited by 47
A metalloproteomic analysis of interactions between plasma proteins and zinc: elevated fatty acid levels affect zinc distribution
Coverdale, J. P. C., Barnett, J. P., Adamu, A. H., Griffiths, E. J., Stewart, A. J., & Blindauer, C. A. (2019) · Metallomics · doi:10.1039/c9mt00177h · Cited by 45
Alzheimer’s Disease, a Lipid Story: Involvement of Peroxisome Proliferator-Activated Receptor α
Sáez-Orellana, F., Octave, J., & Pierrot, N. (2020) · Cells · doi:10.3390/cells9051215 · Cited by 47
Phospholipases in neuronal function: A role in learning and memory?
Joensuu, M., Wallis, T. P., Saber, S. H., & Meunier, F. A. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14918 · Cited by 47
A metabolite panel that differentiates Alzheimer's disease from other dementia types
Jia, L., Yang, J., Zhu, M., Pang, Y., Wang, Q., Wei, Q., Li, Y., Li, T., Li, F., Wang, Q., et al. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12484 · Cited by 46
DDHD2 provides a flux of saturated fatty acids for neuronal energy and function
Saber, S. H., Yak, N., Yong, X. L. H., Bong, Y. T., Leeson, H., Dai, C.-Y., Binder, T., Lu, S., Purushothaman, R., Lenaerts, A.-S., et al. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01367-x · Cited by 44
Proximal Pathway Enrichment Analysis for Targeting Comorbid Diseases via Network Endopharmacology
Aguirre‐Plans, J., Piñero, J., Menche, J., Sanz, F., Furlong, L. I., Schmidt, H. H. H. W., Oliva, B., & Güney, E. (2018) · Pharmaceuticals · doi:10.3390/ph11030061 · Cited by 45
Panoramic Visualization of Circulating MicroRNAs Across Neurodegenerative Diseases in Humans
Brennan, S. E., Keon, M., Liu, B., Su, Z., & Saksena, N. K. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1615-1 · Cited by 44
Sex-specific hippocampal metabolic signatures at the onset of systemic inflammation with lipopolysaccharide in the APPswe/PS1dE9 mouse model of Alzheimer’s disease
Agostini, A., Ding, Y., Bai, L., Kendall, D. A., & Pardon, M. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.09.019 · Cited by 43
Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition
Ooi, K.-L. M., Vacy, K., & Boon, W. C. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105143 · Cited by 42
Modulating Effect of Diet on Alzheimer’s Disease
Fernández-Sanz, P., Ruiz-Gabarre, D., & García‐Escudero, V. (2019) · Diseases · doi:10.3390/diseases7010012 · Cited by 41
Palmitic acid induces insulin resistance by a mechanism associated with energy metabolism and calcium entry in neuronal cells
Sánchez‐Alegría, K., Bastián‐Eugenio, C. E., Vaca, L. A., & Arias, C. (2021) · The FASEB Journal · doi:10.1096/fj.202100243r · Cited by 40
Unravelling the effects of multiple experimental factors in metabolomics, analysis of human neural cells with hydrophilic interaction liquid chromatography hyphenated to high resolution mass spectrometry
González‐Ruiz, V., Pezzatti, J., Roux, A., Stoppini, L., Boccard, J., & Rudaz, S. L. (2017) · Journal of Chromatography A · doi:10.1016/j.chroma.2017.10.055 · Cited by 39
Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease
Gross, T. J., Doran, E. W., Cheema, A. K., Head, E., Lott, I. T., & Mapstone, M. E. (2019) · Developmental Neurobiology · doi:10.1002/dneu.22716 · Cited by 42
Synapses, Microglia, and Lipids in Alzheimer’s Disease
Paasila, P. J., Aramideh, J. A., Sutherland, G. T., & Graeber, M. B. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.778822 · Cited by 40
Targeting Inflammatory Pathways in Alzheimer’s Disease: A Focus on Natural Products and Phytomedicines
Sharman, M. J., Verdile, G., Shanmugam, K., Parenti, C., Singh, A., Watt, G., Karl, T., Chang, D., Li, C. G., & Münch, G. W. (2019) · CNS Drugs · doi:10.1007/s40263-019-00619-1 · Cited by 40
Peripheral serum metabolomic profiles inform central cognitive impairment
Wang, J., Wei, R., Xie, G., Arnold, M., Kueider‐Paisley, A., Louie, G., Dehkordi, S. M., Blach, C., Baillie, R., Han, X., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70703-w · Cited by 38
Imaging Genetics Study Based on a Temporal Group Sparse Regression and Additive Model for Biomarker Detection of Alzheimer’s Disease
Huang, M., Chen, X., Yu, Y., Lai, H., & Feng, Q. (2021) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2021.3057660 · Cited by 40
Altered SPMs and age‐associated decrease in brain DHA in APOE4 female mice
Martinsen, A., Tejera, N., Vauzour, D., Harden, G., Dick, J., Shinde, S., Barden, A. E., Mori, T. A., & Minihane, A. M. (2019) · The FASEB Journal · doi:10.1096/fj.201900423r · Cited by 38
Oxylipin Profiling of Alzheimer’s Disease in Nondiabetic and Type 2 Diabetic Elderly
Morris, J. K., Piccolo, B. D., John, C. S., Green, Z. D., Thyfault, J. P., & Adams, S. H. (2019) · Metabolites · doi:10.3390/metabo9090177 · Cited by 36
Evidence in support of chromosomal sex influencing plasma based metabolome vs APOE genotype influencing brain metabolome profile in humanized APOE male and female mice
Shang, Y., Mishra, A., Wang, T., Wang, Y., Desai, M. K., Chen, S., Mao, Z., Do, L., Bernstein, A. S., Trouard, T. P., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0225392 · Cited by 36
Blood biomarkers indicate that the preclinical stages of Alzheimer's disease present overlapping molecular features
Costanzo, A. D., Paris, D., Melck, D. J., Angiolillo, A., Corso, G., Maniscalco, M., & Motta, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-71832-y · Cited by 34
Early Onset of Sex-Dependent Mitochondrial Deficits in the Cortex of 3xTg Alzheimer’s Mice
Djordjevic, J., Chowdhury, S. R., Snow, W. M., Pérez, C. I., Cadonic, C., Fernyhough, P., & Albensi, B. C. (2020) · Cells · doi:10.3390/cells9061541 · Cited by 36
Redox signaling and Alzheimer’s disease: from pathomechanism insights to biomarker discovery and therapy strategy
Chen, Y.-Y., Wang, M.-C., Wang, Y.-N., Hu, H.-H., Liu, Q.-Q., Liu, H.-J., & Zhao, Y.-Y. (2020) · Biomarker Research · doi:10.1186/s40364-020-00218-z · Cited by 33
Novel insights into brain lipid metabolism in Alzheimer's disease: Oligodendrocytes and white matter abnormalities
Kawade, N., & Yamanaka, K. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13661 · Cited by 35
The DDHD2-STXBP1 interaction mediates long-term memory via generation of saturated free fatty acids
Akefe, I. O., Saber, S. H., Matthews, B., Venkatesh, B. G., Gormal, R. S., Blackmore, D. G., Alexander, S., Sierecki, E., Gambin, Y., Bertran‐Gonzalez, J., et al. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00030-7 · Cited by 32
Assessment of Lipid Peroxidation in Alzheimer’s Disease Differential Diagnosis and Prognosis
Ferré‐González, L., Peña‐Bautista, C., Baquero, M., & Cháfer‐Pericás, C. (2022) · Antioxidants · doi:10.3390/antiox11030551 · Cited by 34
Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?
Yin, C., Harms, A. C., Hankemeier, T., Kindt, A. S. D., & de Lange, E. C. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054960 · Cited by 33

Authors: Snowden, S. G., Ebshiana, A. A., Hye, A., An, Y., Pletnikova, O., O’Brien, R., Troncoso, J., Legido-Quigley, C., & Thambisetty, M.
Affiliations: King's College London (GB)
National Institute on Aging (US)
Duke University (US)
Johns Hopkins University (US)
Corresponding author: Thambisetty, Madhav
ORCID: Snowden, Stuart G.
Hye, Abdul
An, Yang
O’Brien, Richard
Thambisetty, Madhav
Venue: PLOS Medicine
Publisher: Public Library of Science (PLoS)
Published: 2017-03-21
Volume: 14
Issue: 3
Pages: e1002266
ISSN: 1549-1277 (ISSN-L)
1549-1676
DOI: 10.1371/journal.pmed.1002266
PMC: PMC5360226
OpenAlex: W2600991905
Cited by: 309
References: 68
Citations by year: 2026: 21 · 2025: 39 · 2024: 33 · 2023: 32 · 2022: 30 · 2021: 42 · 2020: 42 · 2019: 35 · 2018: 22 · 2017: 12
FWCI: 22.47
Type: journal article
Language: en
Open access: gold
doi.org
Licence: public-domain
creativecommons.org/publicdomain/zero/1.0/ (vor)
Locations: PLoS Medicine (publishedVersion, public-domain)
PubMed Central (publishedVersion, public-domain)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Figshare (submittedVersion, cc-by)
Research Portal (King's College London) (submittedVersion, public-domain)
Funders: Innovative Medicines Initiative. (European Medical Information Framework grant agreement no. 115372)
Innovative Medicines Initiative (European Medical Information Framework grant agreement no. 115372)
libyan cultural attache (7922)
Intramural Research Program of the NIH, National Institute on Aging
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, brain fatty acid metabolism, unsaturated fatty acids, omega-3 fatty acids, omega-6 fatty acids, docosahexaenoic acid, eicosapentaenoic acid, linoleic acid, arachidonic acid, linolenic acid, oleic acid, Alzheimer's disease pathology, cognitive performance, middle frontal gyrus, inferior temporal gyrus, cerebellum
MeSH terms: Aged, Aged, 80 and over, Alzheimer Disease, Brain, Cognition, Fatty Acids, Female, Humans, Longitudinal Studies, Male, Middle Aged, Baltimore, Metabolome, Cognitive Dysfunction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Association between fatty acid metabolism in the brain and Alzheimer disease neuropathology and cognitive performance: A nontargeted metabolomic study

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks